What is thought to be happening is that there's a combination effect
275 : G1415G1422
My Prediction: Where This Is Headed I expect GLP-1 receptor agonists to remain on the WADA monitoring list through at least 2027
For hypothyroid patients considering GLP-1, understanding your genetic profile for weight regulation and metabolic efficiency can support a more informed discussion with your provider about whether rapid weight loss might necessitate earlier or more frequent TSH monitoring
For those who do feel it, the sensation is usually described as a mild, temporary pinch or a localized burn that disappears shortly after the needle is removed
However, a retrospective cohort study of electronic health records involving 240,618 patients with overweight or obesity prescribed semaglutide or non-GLP-1 receptor agonist antiobesity medications, and 1,589,855 patients with type 2 diabetes prescribed semaglutide or other hypoglycaemic agents, found a lower risk of suicidal ideation in patients prescribed semaglutide regardless of prior psychiatric history
